Group One Trading’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7K Sell
1,700
-2,100
-55% -$19.5K ﹤0.01% 6344
2025
Q4
$46.6K Sell
3,800
-3,400
-47% -$55.6K ﹤0.01% 5657
2025
Q3
$148K Buy
7,200
+5,400
+300% +$85.7K ﹤0.01% 4978
2025
Q2
$24.3K Sell
1,800
-35,400
-95% -$387K ﹤0.01% 6129
2025
Q1
$322K Buy
37,200
+37,100
+37,100% +$227K ﹤0.01% 3511
2024
Q4
$486 Hold
100
﹤0.01% 7004
2024
Q3
$772 Sell
100
-63,600
-100% -$565K ﹤0.01% 6326
2024
Q2
$637K Buy
63,700
+63,600
+63,600% +$699K ﹤0.01% 2352
2024
Q1
$1.22K Sell
100
-147,500
-100% -$2.14M ﹤0.01% 6591
2023
Q4
$2.11M Buy
147,600
+32,700
+28% +$314K 0.01% 1825
2023
Q3
$894K Sell
114,900
-229,100
-67% -$2.49M ﹤0.01% 2377
2023
Q2
$4.92M Buy
344,000
+21,100
+7% +$300K 0.02% 963
2023
Q1
$4.72M Sell
322,900
-171,300
-35% -$2.87M 0.02% 869
2022
Q4
$8.3M Sell
494,200
-71,200
-13% -$1.23M 0.02% 844
2022
Q3
$8.38M Buy
565,400
+61,600
+12% +$1.22M 0.02% 830
2022
Q2
$13.8M Buy
503,800
+81,300
+19% +$2.41M 0.02% 665
2022
Q1
$15.9M Sell
422,500
-96,500
-19% -$4.27M 0.02% 721
2021
Q4
$32.2M Sell
519,000
-63,800
-11% -$4.83M 0.03% 460
2021
Q3
$49.9M Buy
582,800
+171,700
+42% +$10.8M 0.05% 280
2021
Q2
$25.4M Buy
411,100
+20,300
+5% +$1.03M 0.03% 500
2021
Q1
$19.1M Buy
390,800
+305,500
+358% +$14.7M 0.03% 561
2020
Q4
$2.66M Buy
85,300
+29,900
+54% +$732K ﹤0.01% 1800
2020
Q3
$1.16M Buy
55,400
+7,400
+15% +$127K ﹤0.01% 2067
2020
Q2
$625K Buy
+48,000
New +$522K ﹤0.01% 2449
2019
Q4
Sell
-41,800
Closed -$605K 5480
2019
Q3
$605K Buy
+41,800
New +$647K ﹤0.01% 2166

Other funds holding OPRX

Group One Trading's OPRX Position: Q1 2026 in Review

Group One Trading reduced its OptimizeRx (OPRX) stake by 84% in Q1 2026, selling an estimated $62.8K and leaving 1,284 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #6480.

Group One Trading first reported a position in OPRX in Q4 2019 and has held it in 11 quarters since. The position peaked at $3.39M in Q1 2022. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Group One Trading held 1,284 shares of OptimizeRx worth $8.06K as of Q1 2026.
  • Group One Trading sold 6,767 OptimizeRx shares in Q1 2026, an estimated $62.8K.
  • OptimizeRx made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6480 holding.
  • Group One Trading first reported a position in OptimizeRx in Q4 2019 and has held it in 11 quarters since.
  • Group One Trading's OptimizeRx position peaked at $3.39M in Q1 2022.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.